ReviewVaccines2022
The Landscape of COVID-19 Vaccination in Zimbabwe: A Narrative Review and Analysis of the Strengths, Weaknesses, Opportunities and Threats of the Programme.
Review in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Equitable access to the COVID-19 vaccines in Africa (ECOVA) findings from a qualitative enquiry in Zimbabwe.Frontiers in health services · 2026Article
- Zimbabwe adverse events following immunisation surveillance system: A descriptive study with COVID-19 vaccine safety updates.Southern African journal of infectious diseases · 2026Article
- Changes in Age-Specific Pregnancy Prevalence Proportions over the Covid-19 Pandemic in Manicaland, Zimbabwe.medRxiv : the preprint server for health sciences · 2025Article
- Real-world COVID-19 vaccine effectiveness in Zimbabwe: A test-negative case-control study.Journal of public health in Africa · 2025Article
- Perspectives on the COVID-19 Vaccination Rollout in 17 Countries: Reflexive Thematic and Frequency Analysis Based on the Strengths, Weaknesses, Opportunities, and Threats (SWOT) Framework.JMIR human factors · 2024Article
- The impact of COVID-19 on sexual risk behaviour for HIV acquisition in east Zimbabwe: An observational study.PLOS global public health · 2024Article
- Systematic documentation of the introduction of COVID-19 vaccines in Latin America and the Caribbean.Revista panamericana de salud publica = Pan American journal of public health · 2024Article
- Exploring COVID-19 vaccine uptake among healthcare workers in Zimbabwe: A mixed methods study.medRxiv : the preprint server for health sciences · 2023Article
- Addressing sociodemographic disparities in COVID-19 vaccine uptake among youth in Zimbabwe.BMJ global health · 2023Article
- Special Issue "New Insights into Current and Future Vaccines against SARS-CoV-2 Variants of Concern and Interest".Vaccines · 2023Article
- Article
- Exploring COVID-19 vaccine uptake among healthcare workers in Zimbabwe: A mixed methods study.PLOS global public health · 2023Article
- Hesitancy, ignorance or uncertainty? The need for effective communication strategies as Zimbabwe's uptake of COVID-19 vaccine booster doses remains poor.Public health in practice (Oxford, England) · 2022Article
- Maternal, Sexual and Reproductive Health in Marginalised Areas: Renewing Community Involvement Strategies beyond the Worst of the COVID-19 Pandemic.International journal of environmental research and public health · 2022Article
- Get vaccinated or else…employees' perspective on mandatory vaccination in the retail sector in Zimbabwe.Frontiers in psychology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ongoing COVID-19 pandemic brought unprecedented challenges for the population. The advent of national COVID-19 vaccination programmes was therefore welcome as a key control strategy for the COVID-19 pandemic, as evidence has shown that vaccination is the best strategy to reduce the adverse individual and population level adverse outcomes associated with infectious diseases such as COVID-19. Zimbabwe rolled out its vaccination programme in February 2021 with an ambitious target to vaccinate at least 60% of its eligible population by December 2021. However, by that time, the country was still to reach that target. To move the vaccination programme towards achieving this target, it is crucial to understand the strengths, weaknesses, opportunities and threats to the programme. We, therefore, with this narrative review, discuss some of the strengths, weaknesses, opportunities and threats to the programme since its rollout in February 2021. Though the programme has several strengths and opportunities to leverage on, we argue that among other challenges, the emergence of new variants of concern poses one of the biggest threats to local, regional and international vaccination programmes and requires concerted multistakeholder efforts to deal with. Additionally, addressing vaccine hesitancy remains as important as availing the vaccines to the population, to obtain the most benefits out of the programme.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.